Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fresenius Kabi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients at least 18 years old who agree to participate in the study and do not object to the use of their health data
A disorder treated with anti-TNF therapy
Whose physician made the decision to initiate adalimumab treatment prior to the study
You may not be if
Patients participating in an interventional therapeutic trial at the time of inclusion
Patients who are unwilling or unable to fulfil follow-up requirements (patients who cannot be reached by phone or complete the self-administered questionnaire or not fluent in French
Clareo Health | A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
